A detailed history of Insight Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Insight Wealth Partners, LLC holds 3,854 shares of ABBV stock, worth $635,871. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,854
Previous 3,850 0.1%
Holding current value
$635,871
Previous $660,000 15.3%
% of portfolio
0.15%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $655 - $797
4 Added 0.1%
3,854 $761,000
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $143,838 - $163,890
-900 Reduced 18.95%
3,850 $701,000
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $55,039 - $63,715
-412 Reduced 7.98%
4,750 $708,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $79,506 - $98,940
-600 Reduced 10.41%
5,162 $695,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $833,242 - $959,603
5,762 New
5,762 $918,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Insight Wealth Partners, LLC Portfolio

Follow Insight Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Wealth Partners, LLC with notifications on news.